The July 24 event aims to inspire accessible and impactful philanthropy by breaking down barriers to meaningful change.

Gilead Sciences, Inc. (NASDAQ: GILD) is one of the. The company announced that the US FDA approved Yeztugo ® (lenacapavir), ...

This article discusses the DOJ’s growing crackdown on healthcare fraud, focusing on illegal speaker programs like Gilead’s $202 million settlement. It stresses the importance of strong compliance, ...

Assembly Biosciences, Inc. (NASDAQ:ASMB) is among the best growth stocks to invest in for the next 5 years. In the wake of ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following CD19-directed CAR-T, according to results of a phase 1 study.More than 80% ...

"Ligand has been an incredible partner over the past few years, and we look forward to their continued guidance and support ...